$LIS · LIS Technologies Inc
Amendment No. 2 to LIS Technologies' S-1 registers a firm-commitment IPO of 3,100,000 common shares at an assumed $6.00 midpoint ($5.00-$7.00 range), with a 30-day over-allotment option for 465,000 additional shares. The company has applied to list on Nasdaq under 'LIS' and has no prior public market. LIS is a pre-revenue, early-stage laser uranium enrichment company that has accumulated net losses of $65,418,743 from inception (Dec 31, 2021) through July 31, 2026.
- Offering: 3,100,000 shares at $5.00-$7.00, assumed $6.00 midpoint, firm commitment.
- Underwriting discount of 6.5% per share plus 1.15% non-accountable expense allowance.
- Underwriters get warrants for 7% of shares sold at 115% of IPO price.
- CEO Jay Jiang Yu and President Christo J. Liebenberg each indicated interest in buying up to $250,000 of shares.
- No revenues to date; accumulated net losses of $65,418,743 through July 31, 2026.
Price data unavailable.
A pre-revenue uranium enrichment startup is seeking a Nasdaq IPO to fund commercialization of its CRISLA laser technology amid a U.S. push to onshore nuclear fuel supply.
LIS positions itself as the only company with U.S.-origin patented laser uranium enrichment technology, targeting demand driven by the 2024 Prohibiting Russian Uranium Imports Act.
No revenues and $65.4M accumulated losses; commercial production requires NRC licenses not yet obtained. Nasdaq listing approval is not assured and is a condition to closing.